Cargando…
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
Judicious use of real‐world data (RWD) is expected to make all steps in the development and use of pharmaceuticals more effective and efficient, including research and development, regulatory decision making, health technology assessment, pricing, and reimbursement decisions and treatment. A “learni...
Autores principales: | Eichler, Hans‐Georg, Bloechl‐Daum, Brigitte, Broich, Karl, Kyrle, Paul Alexander, Oderkirk, Jillian, Rasi, Guido, Santos Ivo, Rui, Schuurman, Ad, Senderovitz, Thomas, Slawomirski, Luke, Wenzl, Martin, Paris, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587701/ https://www.ncbi.nlm.nih.gov/pubmed/30178490 http://dx.doi.org/10.1002/cpt.1226 |
Ejemplares similares
-
Big Data – How to Realize the Promise
por: Cave, Alison, et al.
Publicado: (2020) -
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
por: Stolk, Pieter, et al.
Publicado: (2009) -
Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth
por: Eichler, Hans‐Georg, et al.
Publicado: (2020) -
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
por: Eichler, Hans‐Georg, et al.
Publicado: (2019) -
Arrestins: structural disorder creates rich functionality
por: Gurevich, Vsevolod V., et al.
Publicado: (2018)